Principle Scientist, Bioprocessing Technology Institute, A*Star, Singapore
Global Engage is pleased to announce the Vaccines R&D and Commercialisation Congress Asia, co-located with Biologics and Biosimilars Congress Asia which will take place in Singapore on the 27th and 28th November 2018. This event features over 30 expert speakers across two days and is expected to attract more than 150 attendees and 20 poster presentations. The conference is part of Global Engage’s successful Drug Discovery series which includes our Precision Medicine, Medicinal Chemistry, and Synthetic Biology congresses.
Attracting industry and academic experts working in all areas of immunology, virology, cell biology and molecular biology, this two-day interactive meeting offers you an outstanding opportunity to meet and network with your peers on vaccine development, its progression and commercialisation in Asia. Leading experts share their insights and strategies that will enable you to fully characterise cell-level immunology, develop effective prognostic and predictive biomarkers, and understand the status of immune system. The meeting combines plenary sessions, set presentations, case studies, and panel discussions where your participates is encouraged.
Take this opportunity to meet your potential collaborators, keep abreast of your competitors and explore the latest technology advancements in this area.